CODX
NASDAQ
$2.44
Co-Diagnostics Inc (CODX)
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
Sector:
Healthcare
Industry:
Medical Devices
Target: $45 (+1744.26%)
Market Cap
$8.97M
P/B Ratio
0.59
Beta (5Y)
1.85
Price Chart
Valuation
Market Cap$8.97M
Forward P/E15.36
P/S13.19
P/B0.59
Profitability
Total Revenue (TTM)$718K
Gross Profit (TTM)$324K
EBITDA-$50M
Operating Margin-6309%
EPS-$24.91
Growth & Risk
Revenue 5Y CAGR-59.68%
Beta (5Y)1.85
Sharpe Ratio0.74